Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time
J Clin Oncol
.
2008 Apr 20;26(12):1919-21.
doi: 10.1200/JCO.2007.14.7744.
Epub 2008 Mar 10.
Authors
Nancy U Lin
,
Eric P Winer
PMID:
18332468
DOI:
10.1200/JCO.2007.14.7744
No abstract available
Publication types
Comment
Editorial
MeSH terms
Breast Neoplasms / drug therapy*
Breast Neoplasms / metabolism*
Disease-Free Survival
Humans
Randomized Controlled Trials as Topic
Receptors, Estrogen / biosynthesis*
Survival Rate
Substances
Receptors, Estrogen